<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Towner RA</submitter><funding>NCRR NIH HHS</funding><funding>NIAMS NIH HHS</funding><pagination>77-90; discussion 91</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3555701</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>72(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Glioblastoma multiforme (GBM), a high-grade glioma, is characterized by being diffuse, invasive, and highly angiogenic and has a very poor prognosis. Identification of new biomarkers could help in the further diagnosis of GBM.&lt;h4>Objective&lt;/h4>To identify ELTD1 (epidermal growth factor, latrophilin, and 7 transmembrane domain-containing protein 1 on chromosome 1) as a putative glioma-associated marker via a bioinformatic method.&lt;h4>Methods&lt;/h4>We used advanced data mining and a novel bioinformatics method to predict ELTD1 as a potential novel biomarker that is associated with gliomas. Validation was done with immunohistochemistry, which was used to detect levels of ELTD1 in human high-grade gliomas and rat F98 glioma tumors. In vivo levels of ELTD1 in rat F98 gliomas wer</pubmed_abstract><journal>Neurosurgery</journal><pubmed_title>ELTD1, a potential new biomarker for gliomas.</pubmed_title><pmcid>PMC3555701</pmcid><funding_grant_id>P20 RR020143</funding_grant_id><funding_grant_id>AR092-049</funding_grant_id><funding_grant_id>5P20RR020143-07</funding_grant_id><pubmed_authors>Lupu F</pubmed_authors><pubmed_authors>Smith N</pubmed_authors><pubmed_authors>Saunders D</pubmed_authors><pubmed_authors>Towner RA</pubmed_authors><pubmed_authors>Giles CB</pubmed_authors><pubmed_authors>Vaillant B</pubmed_authors><pubmed_authors>Casteel R</pubmed_authors><pubmed_authors>Gillespie DL</pubmed_authors><pubmed_authors>Colman H</pubmed_authors><pubmed_authors>Silasi-Mansat R</pubmed_authors><pubmed_authors>Jensen RL</pubmed_authors><pubmed_authors>Wren JD</pubmed_authors></additional><is_claimable>false</is_claimable><name>ELTD1, a potential new biomarker for gliomas.</name><description>&lt;h4>Background&lt;/h4>Glioblastoma multiforme (GBM), a high-grade glioma, is characterized by being diffuse, invasive, and highly angiogenic and has a very poor prognosis. Identification of new biomarkers could help in the further diagnosis of GBM.&lt;h4>Objective&lt;/h4>To identify ELTD1 (epidermal growth factor, latrophilin, and 7 transmembrane domain-containing protein 1 on chromosome 1) as a putative glioma-associated marker via a bioinformatic method.&lt;h4>Methods&lt;/h4>We used advanced data mining and a novel bioinformatics method to predict ELTD1 as a potential novel biomarker that is associated with gliomas. Validation was done with immunohistochemistry, which was used to detect levels of ELTD1 in human high-grade gliomas and rat F98 glioma tumors. In vivo levels of ELTD1 in rat F98 gliomas wer</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Jan</publication><modification>2025-04-26T19:56:45.028Z</modification><creation>2019-03-27T01:03:51Z</creation></dates><accession>S-EPMC3555701</accession><cross_references><pubmed>23096411</pubmed><doi>10.1227/NEU.0b013e318276b29d</doi><doi>10.1227/neu.0b013e318276b29d</doi></cross_references></HashMap>